Aspen is a significant global pharma company with a focus on anesthetics, anti-coagulants and infant milk formula. It has a market cap of R139.6 billion, a PE of 23.55 and a dividend yield of 0.94 per cent. Guest Nesan Nair, Sasfin Securities and resident expert Paul Theron from Vestact decide whether Aspen is hot or not.
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.